Skip to main content

Unable to load price data. Sorry.


Celera Group, Applera Corp. (NASDAQ:CRA.DL)

CAPS Rating: No stars

The Company conducts business through two business segments: Applied Biosystems Group and Celera Genomics Group.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:CRA.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

tenmiles (28.15)
Submitted February 18, 2009

Testing company failing the test today with major sell-off related to poor earnings/limited visibility. Still in a good space long term - likely to take a while, but looks okay to nibble at this grower in the $7 range; technicals suggest 10-15%… More

gfouras (66.19)
Submitted March 26, 2007

This stock, at one time a Rule Breaker pick, was in the business of cracking the Human Genetic Code, and was ahead of the US Government in the race. Alas, the parent company gutted everything that was useful, read profitable, from this company, and… More



  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about CRA.DL.

No one has written a Pitch for CRA.DL stock yet. Tell us why you think CRA.DL will outperform or underperform against the market.


Find the members with the highest scoring picks in CRA.DL.

No players have picked CRA.DL yet. Tell us why you think CRA.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CRA.DL.